What is Congenital Hyperinsulinism

Congenital Hyperinsulinism (CHI) is a rare genetic condition where the pancreas secretes excessive amounts of insulin, leading to dangerously low blood sugar levels (hypoglycemia). This condition requires prompt medical management to prevent serious complications, such as brain damage, caused by the brain’s inability to access sufficient glucose.

What causes Congenital Hyperinsulinism?

Congenital Hyperinsulinism occurs due to a malfunction in the insulin-secreting beta cells of the pancreas. Normally, these cells release insulin only when blood sugar is high. In patients with Congenital Hyperinsulinism, these cells remain "switched on" regardless of blood glucose levels. This is typically caused by mutations in genes (such as ABCC8 or KCNJ11) that regulate insulin release. The resulting hyperinsulinemia forces blood glucose to plummet, necessitating constant monitoring.

What are the main types of Congenital Hyperinsulinism?

Clinical experts classify Congenital Hyperinsulinism based on how the pancreas is affected, which dictates the treatment approach:

• Focal form: A localized area of the pancreas is affected by overactive cells; this can often be cured through targeted surgery.


• Diffuse form: The entire pancreas is affected, typically requiring medical therapy or, in severe cases, a near-total pancreatectomy.


• Atypical forms: Often milder or transient, these may involve complex genetic interactions or syndromic associations.

How common is Congenital Hyperinsulinism?

Congenital Hyperinsulinism is considered a rare disease, with an estimated incidence ranging from 1 in 25,000 to 1 in 50,000 live births in general populations. However, the prevalence can be significantly higher in communities with higher rates of consanguinity (marriage between relatives). While it affects both genders equally, Congenital Hyperinsulinism usually presents in the newborn period or early infancy, making early diagnosis critical for long-term neurodevelopmental health.

Next steps

• Consult with a pediatric endocrinologist specializing in metabolic disorders.


• Request genetic testing to identify the specific mutation, as this guides the surgical or medical treatment path.


• Join the Congenital Hyperinsulinism group on DiseaseMaps.org to connect with other families and share experiences.


• Monitor blood glucose levels strictly as directed by your clinical team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult a qualified healthcare professional for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Congenital Hyperinsulinism overview.


• Orphanet: Congenital Hyperinsulinism (ORPHA:420).


• OMIM (Online Mendelian Inheritance in Man): Hyperinsulinemic Hypoglycemia.


• Congenital Hyperinsulinism International (CHI): Patient resources and clinical guidelines.